ArticleThe Lancet. Rheumatology2021
Patient-reported wellbeing and clinical disease measures over time captured by multivariate trajectories of disease activity in individuals with juvenile idiopathic arthritis in the UK: a multicentre prospective longitudinal study.
Article in The Lancet. Rheumatology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 24 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed, 30 citations in OpenAlex.
- Trajectories of Physical Function in Canadian Children With Juvenile Idiopathic Arthritis.Arthritis care & research · 2026Article
- Adherence to treat-to-target recommendations in juvenile idiopathic arthritis in clinical practice.Pediatric rheumatology online journal · 2026Observational
- Opinions on contributing data to research studies: survey results from adults living with juvenile idiopathic arthritis (JIA).Rheumatology (Oxford, England) · 2026Article
- A stratified approach to juvenile idiopathic arthritis: leveraging machine learning to uncover subgroups of patients following treatment with etanercept.Rheumatology advances in practice · 2026Article
- A Canadian Advanced Physiotherapist Practitioner Shared-Care Model in Pediatric Rheumatology Offers Safe and Quality Care in the Management of Juvenile Idiopathic Arthritis-Comparing Key Performance Indicators with the PR-COIN Registry.Children (Basel, Switzerland) · 2025Article
- The interplay between pain and disease activity: personal models of pain beliefs and emotional representations in children and young people with juvenile idiopathic arthritis in a UK nationwide prospective inception cohort.Journal of pediatric psychology · 2025Article
- Trajectories of physical, mental health and health satisfaction before and after arthritis diagnosis: a UK population-based study.BMC musculoskeletal disorders · 2025Article
- Greater DMARD use, improved clinical but not patient-reported outcomes in juvenile idiopathic arthritis: what are we missing?Rheumatology (Oxford, England) · 2024Article
- Detection of inflammation by whole-body MRI in young people with juvenile idiopathic arthritis.Rheumatology (Oxford, England) · 2024Article
- The impact of psoriasis on wellbeing and clinical outcomes in juvenile psoriatic arthritis.Rheumatology (Oxford, England) · 2024Article
- Disease activity trajectories from childhood to adulthood in the population-based Nordic juvenile idiopathic arthritis cohort.RMD open · 2024Article
- The importance of ultrasound examination in care of juvenile idiopathic arthritis patients: 9 months follow-up study.Frontiers in pediatrics · 2024Article
- Health-related quality of life profiles in adolescents and young adults with chronic conditions.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2023Article
- Continuing specialist care into adulthood in young people with juvenile idiopathic arthritis: a retrospective cohort study using electronic health records in England.Rheumatology (Oxford, England) · 2023Article
- Evaluating key performance indicators of the process of care in juvenile idiopathic arthritis.Pediatric rheumatology online journal · 2023Article
- Validation of the parent global assessment as a health-related quality of life measure in juvenile idiopathic arthritis: results from ReACCh-Out.Rheumatology (Oxford, England) · 2023Article
- No evidence that genetic predictors of susceptibility predict changes in core outcomes in JIA.Rheumatology (Oxford, England) · 2022Article
- Treat to Target (Drug-Free) Inactive Disease in JIA: To What Extent Is This Possible?Journal of clinical medicine · 2022Review
- Association Between Patient-Reported Outcomes and Treatment Failure in Juvenile Idiopathic Arthritis.ACR open rheumatology · 2022Article
- Latent classes of early response trajectories to biologics initiation in juvenile idiopathic arthritis: an analysis of four trials.Pediatric rheumatology online journal · 2022Article
Corrections and comments
- Erratum issuedCorrection to2021
Authors and funding
6 authors at 3 institutions in 1 country.
Funding
Abstract
backgroundJuvenile idiopathic arthritis (JIA) is a heterogeneous disease, the signs and symptoms of which can be summarised with use of composite disease activity measures, including the clinical Juvenile Arthritis Disease Activity Score (cJADAS). However, clusters of children and young people might experience different global patterns in their signs and symptoms of disease, which might run in parallel or diverge over time. We aimed to identify such clusters in the 3 years after a diagnosis of JIA. The identification of these clusters would allow for a greater understanding of disease progression in JIA, including how physician-reported and patient-reported outcomes relate to each other over the JIA disease course.
methodsIn this multicentre prospective longitudinal study, we included children and young people recruited before Jan 1, 2015, to the Childhood Arthritis Prospective Study (CAPS), a UK multicentre inception cohort. Participants without a cJADAS score were excluded. To assess groups of children and young people with similar disease patterns in active joint count, physician's global assessment, and patient or parental global evaluation, we used latent profile analysis at initial presentation to paediatric rheumatology and multivariate group-based trajectory models for the following 3 years. Optimal models were selected on the basis of a combination of model fit, clinical plausibility, and model parsimony. FINDING: Between Jan 1, 2001, and Dec 31, 2014, 1423 children and young people with JIA were recruited to CAPS, 239 of whom were excluded, resulting in a final study population of 1184 children and young people. We identified five clusters at baseline and six trajectory groups using longitudinal follow-up data. Disease course was not well predicted from clusters at baseline; however, in both cross-sectional and longitudinal analyses, substantial proportions of children and young people had high patient or parent global scores despite low or improving joint counts and physician global scores. Participants in these groups were older, and a higher proportion of them had enthesitis-related JIA and lower socioeconomic status, compared with those in other groups.
interpretationAlmost one in four children and young people with JIA in our study reported persistent, high patient or parent global scores despite having low or improving active joint counts and physician's global scores. Distinct patient subgroups defined by disease manifestation or trajectories of progression could help to better personalise health-care services and treatment plans for individuals with JIA.
fundingMedical Research Council, Versus Arthritis, Great Ormond Street Hospital Children's Charity, Olivia's Vision, and National Institute for Health Research.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.